tiprankstipranks
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX

Amneal Pharmaceuticals (AMRX) Income Statement

406 Followers

Amneal Pharmaceuticals Income Statement

Last quarter (Q4 2023), Amneal Pharmaceuticals's total revenue was $616.98M, an increase of 1.18% from the same quarter last year. In Q4, Amneal Pharmaceuticals's net income was $-98.65M. See Amneal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.39B$ 2.39B$ 2.21B$ 2.09B$ 1.99B$ 1.63B
Cost of Revenue
$ 1.57B$ 1.57B$ 1.42B$ -1.30B$ 1.36B$ 1.27B
Gross Profit
$ 820.57M$ 820.57M$ 795.82M$ 768.97M$ 628.39M$ 353.00M
Operating Expense
$ 593.87M$ 596.32M$ 596.99M$ 583.12M$ 519.99M$ 538.50M
Operating Income
$ 202.67M$ 204.37M$ -94.93M$ 185.85M$ 108.40M$ -185.51M
Net Non Operating Interest Income Expense
$ -210.63M$ -210.63M$ -158.38M$ -136.32M$ -146.00M$ -168.21M
Other Income Expense
$ 21.19M$ 21.19M$ -16.81M$ -15.13M$ 1.82M$ 133.47M
Pretax Income
$ -40.27M$ -40.27M$ -248.13M$ 31.37M$ -35.78M$ -220.24M
Tax Provision
$ 8.50M$ 8.50M$ 6.70M$ 11.20M$ -104.36M$ 383.33M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -84.03M$ -83.99M$ -129.99M$ 10.62M$ 91.06M$ -361.92M
Basic EPS
$ -0.31$ -0.48$ -0.86$ 0.07$ 0.62$ -2.74
Diluted EPS
$ -0.32$ -0.48$ -0.86$ 0.07$ 0.61$ -2.74
Basic Average Shares
$ 704.54M$ 176.14M$ 150.94M$ 148.92M$ 147.44M$ 132.11M
Diluted Average Shares
$ 704.54M$ 176.14M$ 150.94M$ 151.82M$ 148.91M$ 132.11M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
----$ 0.63$ 0.35
Rent Expense Supplemental
------
Total Expenses
$ 2.17B$ 2.17B$ 2.01B$ -718.88M$ 1.88B$ 1.81B
Net Income From Continuing And Discontinued Operation
$ -87.14M$ -83.99M$ -129.99M$ 10.62M$ 91.06M$ -361.92M
Normalized Income
$ 82.13M$ 68.29M--$ 91.62M$ -458.28M
Interest Expense
----$ 146.00M$ 168.21M
EBIT
$ -35.69M$ -35.69M$ -243.62M$ 26.77M$ 110.22M$ -52.04M
EBITDA
$ 201.90M$ 201.90M$ 5.15M$ 269.37M$ 345.61M$ 155.20M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis